Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines in the areas of rare diseases, gout, ophthalmology, and inflammation. It markets TEPEZZA (teprotumumab-trbw) for intravenous infusion; KRYSTEXXA (pegloticase injection) for intravenous infusion; RAVICTI (glycerol phenylbutyrate) oral liquid; PROCYSBI (cysteamine bitartrate) delayed-release capsules and granules for oral use; ACTIMMUNE (interferon gamma-1b) injection for subcutaneous use; BUPHENYL (sodium phenylbutyrate) tablets and powder for oral use; QUINSAIR (levofloxacin) solution for inhalation; and UPLIZNA (inebilizumab-cdon) injection for intravenous use. The company also markets PENNSAID (diclofenac sodium topical solution) for topical use; DUEXIS (ibuprofen/famotidine) tablets for oral use; RAYOS (prednisone) delayed-release tablets for oral use; and VIMOVO (naproxen/esomeprazole magnesium) delayed-release tablets for oral use. It has collaboration agreements with HemoShear Therapeutics, LLC.; Alpine Immune Sciences, Inc.; Halozyme Therapeutics, Inc.; and Arrowhead Pharmaceuticals, Inc. The company was formerly known as Horizon Pharma Public Limited Company and changed its name to Horizon Therapeutics Public Limited Company in May 2019. Horizon Therapeutics Public Limited Company was founded in 2005 and is headquartered in Dublin, Ireland with additional offices in Deerfield, Illinois; Chicago, Illinois; Lake Forest, Illinois; South San Francisco, California; Washington, D.C.; Gaithersburg, Maryland; Rockville, Maryland; and Mannheim, Germany. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Horizon Therapeutics Public Limited Company Ordinary Shares.
Horizon Therapeutics Public Limited Company Ordinary Shares business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Horizon Therapeutics Public Limited Company Ordinary Shares are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Horizon Therapeutics Public Limited Company Ordinary Shares , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Horizon Therapeutics Public Limited Company Ordinary Shares including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Horizon Therapeutics Public Limited Company Ordinary Shares and all latest updates of the company are provided.
The 2025 version of Horizon Therapeutics Public Limited Company Ordinary Shares report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Horizon Therapeutics Public Limited Company Ordinary Shares- Key Facts
2.2 Horizon Therapeutics Public Limited Company Ordinary Shares- Geographic Locations
2.3 Horizon Therapeutics Public Limited Company Ordinary Shares- Subsidiaries and Affiliates
2.4 Horizon Therapeutics Public Limited Company Ordinary Shares- Business Divisions
2.5 Horizon Therapeutics Public Limited Company Ordinary Shares- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Horizon Therapeutics Public Limited Company Ordinary Shares Strategic Analysis Review
3.1 Horizon Therapeutics Public Limited Company Ordinary Shares- Key Strategies
3.2 Horizon Therapeutics Public Limited Company Ordinary Shares- Company Outlook Statement
3.3 Horizon Therapeutics Public Limited Company Ordinary Shares- SWOT Analysis
3.3.1 Horizon Therapeutics Public Limited Company Ordinary Shares- Key Strengths
3.3.2 Horizon Therapeutics Public Limited Company Ordinary Shares- Key Weaknesses
3.3.3 Horizon Therapeutics Public Limited Company Ordinary Shares- Potential Opportunities
3.3.4 Horizon Therapeutics Public Limited Company Ordinary Shares- Potential Threats
3.4 Horizon Therapeutics Public Limited Company Ordinary Shares- Key Competitors
4. Business Description of the Company
4.1 Horizon Therapeutics Public Limited Company Ordinary Shares- Business Overview
4.2 Horizon Therapeutics Public Limited Company Ordinary Shares- Operations by Segment
5 Products and Services Details
5.1 Horizon Therapeutics Public Limited Company Ordinary Shares- Key Products
5.2 Horizon Therapeutics Public Limited Company Ordinary Shares- Key Service Areas
5.3 Horizon Therapeutics Public Limited Company Ordinary Shares- Key Brands
6 Company Developments
6.1 Horizon Therapeutics Public Limited Company Ordinary Shares- Company History
6.2 Horizon Therapeutics Public Limited Company Ordinary Shares- Latest Developments
7 Financial Analysis
7.1 Horizon Therapeutics Public Limited Company Ordinary Shares- Income Statements
7.2 Horizon Therapeutics Public Limited Company Ordinary Shares- Balance Sheet
7.3 Horizon Therapeutics Public Limited Company Ordinary Shares- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Horizon Therapeutics Public Limited Company Ordinary Shares- Direct Competitors
8.2 Horizon Therapeutics Public Limited Company Ordinary Shares- Competitor Financial Ratios comparison
8.3 Horizon Therapeutics Public Limited Company Ordinary Shares- Competitor Stock Charts Comparison
8.4 Horizon Therapeutics Public Limited Company Ordinary Shares- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 630 95 25755
- sales@swotreports.com
-
Chat on WhatsApp
